Sinphar Pharmaceutical Co Ltd Financial Flexibility Index
Sinphar Pharmaceutical Co Ltd financial flexibility index. Sinphar Pharmaceutical Co Ltd (1734) has a Financial Flexibility Index of 0.08x as of March 2026. Free cash flow of NT$217.49 Million (operating CF NT$116.42 Million minus capex NT$101.07 Million) represents 0% of total liabilities (NT$2.61 Billion). Explore Sinphar Pharmaceutical Co Ltd (1734) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sinphar Pharmaceutical Co Ltd (2003–2025)
Financial flexibility index of Sinphar Pharmaceutical Co Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Sinphar Pharmaceutical Co Ltd across 23 annual periods. Check Sinphar Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sinphar Pharmaceutical Co Ltd Financial Flexibility Index by Year (2003–2025)
Sinphar Pharmaceutical Co Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Sinphar Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 1734 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | NT$785.61 Million | NT$584.66 Million | NT$2.44 Billion | ▲ +4.3% |
| 2024 | 0.31x | NT$850.23 Million | NT$593.51 Million | NT$2.75 Billion | ▲ +47.6% |
| 2023 | 0.21x | NT$597.31 Million | NT$296.37 Million | NT$2.85 Billion | ▲ +7.4% |
| 2022 | 0.19x | NT$578.74 Million | NT$425.30 Million | NT$2.97 Billion | ▲ +106.4% |
| 2021 | 0.09x | NT$296.99 Million | NT$135.54 Million | NT$3.14 Billion | ▼ -7.3% |
| 2020 | 0.10x | NT$304.16 Million | NT$146.39 Million | NT$2.98 Billion | ▲ +184.5% |
| 2019 | 0.04x | NT$97.25 Million | NT$-79.49 Million | NT$2.71 Billion | ▼ -73.8% |
| 2018 | 0.14x | NT$335.19 Million | NT$79.50 Million | NT$2.46 Billion | ▼ -15.6% |
| 2017 | 0.16x | NT$390.87 Million | NT$219.87 Million | NT$2.42 Billion | ▲ +25.7% |
| 2016 | 0.13x | NT$312.03 Million | NT$87.18 Million | NT$2.42 Billion | ▼ -54.9% |
| 2015 | 0.29x | NT$692.57 Million | NT$280.53 Million | NT$2.43 Billion | ▲ +53.7% |
| 2014 | 0.19x | NT$442.87 Million | NT$148.58 Million | NT$2.39 Billion | ▼ -54.2% |
| 2013 | 0.41x | NT$895.25 Million | NT$297.09 Million | NT$2.21 Billion | ▲ +38.5% |
| 2012 | 0.29x | NT$539.64 Million | NT$164.45 Million | NT$1.85 Billion | ▼ -1.5% |
| 2011 | 0.30x | NT$587.27 Million | NT$225.58 Million | NT$1.98 Billion | ▼ -16.8% |
| 2010 | 0.36x | NT$554.24 Million | NT$261.49 Million | NT$1.55 Billion | ▲ +0.5% |
| 2009 | 0.36x | NT$529.66 Million | NT$309.94 Million | NT$1.49 Billion | ▲ +28.1% |
| 2008 | 0.28x | NT$504.26 Million | NT$271.01 Million | NT$1.82 Billion | ▼ -31.1% |
| 2007 | 0.40x | NT$589.76 Million | NT$174.85 Million | NT$1.46 Billion | ▲ +7.5% |
| 2006 | 0.37x | NT$416.01 Million | NT$166.57 Million | NT$1.11 Billion | ▲ +43.9% |
| 2005 | 0.26x | NT$310.86 Million | NT$122.09 Million | NT$1.19 Billion | ▼ -20.1% |
| 2004 | 0.33x | NT$335.60 Million | NT$174.81 Million | NT$1.03 Billion | ▼ -4.5% |
| 2003 | 0.34x | NT$381.33 Million | NT$120.84 Million | NT$1.12 Billion | — |